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Abstract: 
Background:  Population ageing will lead to more deaths with an uncertain 
trajectory. Identifying patients at risk of dying could facilitate more 
effective care planning.  
Aim: To determine whether screening for likely death within twelve months 
is more effective using screening tools or intuition.  
Design: RCT of screening tools (ST) (Surprise Question (SQ) plus the 
Supportive and Palliative Care Indicators Tool (SPICT) for SQ+ patients) to 
predict those at risk of death at 12 months compared with unguided 
intuition (I). Clinical trials registry ACTRN12613000266763.  
Setting/Participants:  Australian general practice. Thirty GPs  (ST-12, I-18) 
screened all patients (n=4365) aged ≥70 years seen at least once in the 
last two years.  
Results: There were 142 deaths (ST 3.1%, I 3.3%: p=0.79). GPs identified 
more at risk of dying using SQ (11.8%) than intuition (5.4%:  p=0.01), 
but no difference with SQ+ then SPICT (5.1%: p=0.87). SQ+ predicted 
more deaths (53.2%; I 33.7% p=0.001), but SQ+/SPICT predictions were 
similar (5.1%, p=0.87 vs intuition). There was no difference in proportions 
correctly predicted to die (SQ 1.6%; I 1.1% p=0.156, SQ+/SPICT 1.1%; 
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p= 0.86 vs intuition). ST had higher sensitivity and lower specificity than 
intuition, but no difference in positive or negative predictive value.  
Conclusions:  ST was better at predicting actual death than intuition, but 
with a higher false positive rate.  Both were similarly effective at screening 
the whole cohort for death. Screening for possible death is not the best 
option for initiating end of life planning: recognising increased burden of 
illness might be a better trigger.  
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Abstract 
 
Background:  Population ageing will lead to more deaths with an uncertain trajectory. 
Identifying patients at risk of dying could facilitate more effective care planning. 
Aim: To determine whether screening for likely death within twelve months is more 
effective using screening tools or intuition. 
Design: RCT of screening tools (ST) (Surprise Question (SQ) plus the Supportive and 
Palliative Care Indicators Tool (SPICT) for SQ+ patients) to predict those at risk of death 
at 12 months compared with unguided intuition (I). Clinical trials registry 
ACTRN12613000266763. 
Setting/Participants:  Australian general practice. Thirty GPs  (ST-12, I-18) screened all 
patients (n=4365) aged ≥70 years seen at least once in the last two years. 
Results: There were 142 deaths (ST 3.1%, I 3.3%: p=0.79). GPs identified more at risk of 
dying using SQ (11.8%) than intuition (5.4%:  p=0.01), but no difference with SQ+ then 
SPICT (5.1%: p=0.87). SQ+ predicted more deaths (53.2%; I 33.7% p=0.001), but 
SQ+/SPICT predictions were similar (5.1%, p=0.87 vs intuition). There was no difference 
in proportions correctly predicted to die (SQ 1.6%; I 1.1% p=0.156, SQ+/SPICT 1.1%; p= 
0.86 vs intuition). ST had higher sensitivity and lower specificity than intuition, but no 
difference in positive or negative predictive value.  
Conclusions:  ST was better at predicting actual death than intuition, but with a higher 
false positive rate.  Both were similarly effective at screening the whole cohort for 
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death. Screening for possible death is not the best option for initiating end of life 
planning: recognising increased burden of illness might be a better trigger. 
 
Keywords: general practice, patient screening, end of life, frailty, mulltimorbidity, care 
planning 
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Key statements 
 
What is already known about the topic? 
• Care planning for the end of life improves outcomes.  
• Identifying patients for whom end of life care planning will benefit is difficult. 
Several tools have been produced to help identify those approaching the end of life and 
whose care needs will escalate. It is not known how accurate these are at predicting 
death.  
  
What this paper adds? 
• Using a combination of screening tools to screen patients 70 years and older in 
general practice lists was able to identify patients at risk of dying in 12 months better 
than unguided intuition. 
• However, screening GP lists of patients age 70 and older, using these tools is no 
more accurate than intuition in predicting death at 12 months. 
• Both intuition and the screening process we tested are several times better at 
predicting death than the incidence rates of death in the intuition and screening tool 
populations, but have unacceptably high levels of false positive results for predicting 
dying within 12 months. 
 
Implications for practice, theory or policy? 
• Using current screening tools to screen general practice patient lists to predict 
dying within 12 months is not feasible. 
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• Different triggers to generating care plans in the later stages of life are required. 
Sentinel events like unexpected hospitalisation may be better markers for the need for 
care planning.   
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Background 
Countries worldwide face ageing populations. As people age, their burden of illness 
rises.  Most will die after living for many years with conditions such as frailty, 
multimorbidity, dementia and organ failure, and relatively fewer will die of cancer.[1] 
 
By contrast,  the patients of specialist palliative care services suffer from cancer. [2]  In 
Western Australia, only 8% of people who died of a non-malignant disease accessed 
specialised palliative care services, while 68% of people who died of cancer did so.[3] 
The trajectory of decline in non-cancer disease is more uncertain than that of cancer, 
and the trajectory to death can be much longer.[4] Planning end of life care for these 
conditions is challenging. 
 
The last period of an individual’s life incurs a high proportion of lifetime health 
expenditure.[5] In the USA, different functional trajectories of illness varied in speed and 
intensity of deterioration in the year before entering a hospice program.[6] Forward 
planning for anticipated deterioration may lessen its impact, may allow a person to 
remain at home, may deliver a better sense of control over the situation and more 
peace of mind.  
An approach to this problem has been to identify patients at risk of dying within a 
foreseeable timeframe, usually several months, to then generate an end of life care plan 
that can be enacted when deterioration to death occurs. [7] 
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Numerous instruments aimed at identifying those people at risk of deteriorating 
towards death by recognising the presence of particular physical or other markers.[8] 
The simplest of these is the Surprise Question (SQ), which asks practitioners whether 
they would be surprised if this person were to die within  6-12 months.[9] If the answer 
is “No, I would not be surprised” this indicates a perceived risk of deterioration to death 
(referred to as SQ+  throughout this paper). Other tools developed require practitioners 
to identify general indicators of physical deterioration, and/or specific illness-based 
indicators of decline for the person being considered. The utility of this latter approach 
in identifying individuals at risk of dying has been demonstrated in a range of settings 
where death in the foreseeable future has high prevalence (For example, in acute 
hospital inpatients[10]).   
 
General practices in the UK receive financial incentives to maintain palliative care 
patient registers.[11] Formal screening of general practice patient lists takes time. Many 
health systems, such as the Australian general practice system do not require or fund 
system-level planning like this, so identification of at-risk patients needs to be done 
opportunistically, with the risk that patients will ‘slip through the net’. If done 
systematically, screening needs to be efficient and cost-effective.  
 
We decided to test whether it is it feasible and effective to apply a screening procedure 
to identify people at risk of dying in the foreseeable future, in the Australian general 
practice setting, by conducting a randomised controlled trial (RCT) to test whether a 
Page 12 of 40
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Predicting death in general practice 12
formal screening tool was more effective in predicting foreseeable death than a purely 
intuitive approach. 
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Methods 
Study type 
We undertook a randomised controlled trial of GPs predicting dying in their patients 
using either intuition or a process involving screening tools.  Because this has not been 
done before, we considered this to be an exploratory RCT, with an aim of the study to 
be to calculate statistics to inform sample size calculations for future studies. 
 
Primary and other outcomes 
The primary outcome was the proportion of patients correctly identified as being at risk 
of death at twelve months. Secondary outcomes included test characteristics including 
sensitivity, specificity, positive and negative predictive values, likelihood ratios and pre-
and post-test likelihoods of dying or not dying.  
 
Setting and recruitment 
Practices were recruited through practice-based research networks of the University of 
New South Wales and the University of Queensland, Australia; notices in doctor 
newsletters and direct approaches to practices.  
Australian general practice occurs almost exclusively in private clinics, with multiple 
general practitioners (GPs) and often a practice nurse. There is ready availability of 
pathology, radiology and community specialist support in most GP settings.  Funding is 
through a universal health insurance scheme which is based on fee for service: GPs rely on 
regular patient throughput to generate an income stream. 
Page 14 of 40
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Predicting death in general practice 14
 
Participant Eligibility 
GPs within the participating practices were excluded if they had worked <12 months in 
the practice; were not seeing patients ≥ 70 years of age; or where the practices did not 
use computerised patient records.  
 
Randomization procedure 
Eligible GPs were randomly assigned to either an intuition (I) group or a screening tool 
(ST) group with a 1:1 allocation by a computer generated number sequence with 
stratified permuted blocks of random sizes. GP participants were stratified according to 
years of general practice experience (≤10 or >10 years).  
 
Screening instruments 
We selected the Supportive and Palliative care Indicator Tool (SPICT, 2012 version)[12] 
which helps clinicians identify people who have supportive or palliative care needs. The 
SPICT is a two-step clinical guidance tool. The first step seeks general indicators of 
deteriorating health, the second seeks specific indicators of advanced disease for a 
range of specific conditions including cancer, dementia/frailty, and system-based 
diseases. A combination of two general indicators of deterioration and one specific 
indicator prompts assessment of supportive or palliative care needs (SPICT+).  The SPICT 
has been tested in a range of conditions in hospital[10], but not as a screening tool in 
general practice. 
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Our pilot work indicated that the SPICT took some minutes to complete for each patient, 
so on its own would have been impractical as a screening tool in the study setting. 
Hence we integrated the SQ as a pre-screening tool prior to the full SPICT. We also 
identified that the vast majority of deaths in primary care occurred in patients ≥70 
years. 
 
Study Procedure 
After providing informed consent, we generated a patient list comprising individuals 
aged ≥70 years old who had been seen by study GPs in the last two years. Patients not 
correctly allocated to their lists were reassigned to the correct GP. GPs were asked to 
identify people at risk of dying using one of two methods.  
 
One group (Intuition) was asked to search their list to identify patients they thought 
might die within 12 months, with no external prompts or guides.  The actual question 
asked was: “Please complete one form for each patient under your care and whom you have 
added to your list of patients who will most likely die in the next 12 months.” 
 
The second group (ST) initially screened their patient lists using the SQ, and then 
screened those using the SPICT indicators to identify patients who might die. The SQ 
responses could be SQ+ (answered no to the SQ), SQ- (answered yes to the SQ) or 
uncertain about the possibility of death within 12 months (SQu). The GP then completed 
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the SPICT on SQ+ and SQU patients. Patients who were SQ- were not considered further. 
GPs from both groups were also asked to add any patients aged <70 whom they 
considered at risk of death, to their lists. Intuition group GPs were asked to describe 
briefly the reasons for selecting the patients considered at risk of dying. 
 
Blinding  
Each practice contained GPs in both allocation groups.  In order to minimize 
contamination, those randomised to intuition were given their instructions first. Once 
they had completed screening, the ST GPs in that practice were given their instructions 
and commenced screening. 
 
Follow-up 
We sought deaths that occurred up to twelve months post-baseline through the death 
registries of Queensland and New South Wales, searched eighteen months after 
baseline to maximize the capture of these deaths. 
 
Analysis 
Categorical variables were summarized as frequency (percentage). Participant GP 
characteristics within the groups were assessed using Fisher’s Exact Test. Because of the 
different ways patient characteristics were assessed, a descriptive comparison was 
made, as a statistical comparison was not possible. To calculate diagnostic statistics for 
intuition and ST groups in predicting death within twelve months we used a generalized 
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linear model with binomial family, identity link, and robust standard errors to adjust for 
possible correlation with GPs. Effect estimates are reported as mean difference (MD) 
and 95% confidence interval (95%CI) Likelihood ratios and post-test probabilities were 
calculated using the overall probability of death as the pre-test probability. We 
calculated the intraclass correlation coefficient (ICC) to inform future power calculations 
for studies of this type. [12] Significance was set at P <0.05.  
 
Qualitative data collection and analysis 
Semi-structured interviews were conducted with participants to determine the 
feasibility and acceptability of adopting a case finding approach in general 
practice/primary care; and to explore the barriers and facilitators to implementing this. 
Participants were selected to ensure that views of both male and female participants, 
different ages and clinical experience, practice types and geographical locations were 
represented. The interviews were conducted by telephone, digitally recorded then 
transcribed. Qualitative descriptive methodology informed the analysis. All the coding 
and analysis was undertaken by one investigator (JR); in addition HS and PT jointly 
coded one-third of the interviews and had coding and analysis meetings with JR in order 
to increase the data’s trustworthiness. 
 
Ethics and Trial Registration 
The project was approved by Ethics committees of the University of Queensland 
(2012001275) and the University of New South Wales (HC12553). The trial was 
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registered with the Australian and New Zealand Clinical trials register, number 
ACTRN12613000266763.  
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Results 
General Practitioners and patients 
We recruited 40 GPs from nineteen practices from November 2012 to August 2013. One 
GP dropped out after recruitment but before randomization. Nineteen were allocated to 
the screening tools (ST) process and twenty to the intuition (I) process. We retrieved 
data from eighteen of nineteen (95%) intuition group GPs but only twelve of 19 (63%) ST 
GPs, most citing pressures of work for failure to provide data. (Figure 1). There was no 
difference in the proportions of age or years in practice between the GP groups, but 
more practitioners in the Intuition group trained in countries other than Australia.  The 
difference in gender balance between the groups approached significance (Table 1) 
Patient characteristics appeared similar in each group. (Table 2) The median number of 
patients over 70 assessed by intuition GPs was 129 (range 11, 321; Interquartile range 
(IQR) 73-180.25) and ST was 94 (range 8-481, IQR 52-224.25). The percentage of 
patients where death was predicted ranged from 0.0% to 29.1%, with median = 6.6% , 
when the SPICT positive question was included these figures fell to median = 3.4%, 
range = 0.0% to 29.1%). 
 
ST GPs assessed 1525 patients, and intuition GPs, 2840 patients. Similar proportions of 
patients from each group died (Table 3). Because GPs within the one practice allocated 
to different groups saw the same patient, these patients were counted in the 
assessments more than once. 
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Patients identified as at risk of dying (Primary outcome) 
When ST GPs initially applied the SQ, they identified 179 of 1525 patients (11.7%) who 
might die within twelve months compared with 154 of 2840 (5.4%) identified by 
intuition group GPs, giving a mean difference (MD) between groups of 6.3% (95%CI: 
1.4%, 11.2%; P=0.01). Eight of the identified patients were aged under 70 years (ST=2, 
I=6). When the SPICT was conducted on these 179 patients initially identified with SQ, 
the number of SPICT+ patients (i.e those continuing to be identified as being at risk of 
death) fell to 78 (5.1%), a similar proportion as for intuition alone (MD=-0.3%; 95%CI: -
4.0%, 3.4%; P=0.87) 
 
Deaths recorded at twelve months  
The death registries recorded 142 deaths, 95 (3.3%) in the intuition group and 47 (3.1%) 
in the ST group (MD = -0.3%; 95%CI: -2.2%, 1.6%, P=079). There were no deaths for 
those people under the age of 70. (Table 3) 
 
For patients who died, GPs in the ST group predicted more deaths (25/47; 53.2%) than 
those in the intuition group (32/95; 33.7%), MD=19.5%;95%CI 7.6%, 31.4%; P=0.001).  
However, for all patients reviewed by ST and intervention GPs, the proportion of deaths 
was similar (ST 25/1525 (1.6%); I 32/2840 (1.1%) MD=0.5%; 95%CI: -0.5%, 1.5%; P=0.33). 
When the SQ+ then SPICT process was applied, the proportion of identified deaths fell 
to 16/1525 (1.1%) MD = 0.0%; 95%CI: -0.9%, 0.8%; P=0.86).   
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Comparative ability of intuition and formal tools to predict death 
Sensitivity and specificity of intuition and predictive tools were significantly different, 
with a prediction of SQ+ plus SQU being more sensitive and less specific than intuition. 
The positive and negative predictive values of both groups were similar (Table 4). 
 
 While screening with SQ then SPICT reduced the numbers considered at risk, fewer 
deaths were correctly identified.  There was no difference in sensitivity, specificity, 
positive or negative predictive value compared with intuition alone (Table 4). 
The odds of predicting dying are related to the likelihood ratios of a positive and 
negative test and the prevalence of dying at 12 months in each group. The odds of dying 
with a positive test, or not dying with a negative test, are very similar when either 
intuition, SQ alone, or SQ/SPICT process were applied (Table 4).  In each case, the rate of 
detection was between five to seven times the actual death rate of the population. 
(Table 5)  
 
Intracluster correlation coefficient (ICC) estimation derived from this study 
To inform future trials of this type we calculated ICCs to measure the extent to which 
there are systematic differences between GPs when predicting death in their patients. 
When considering the Surprise Question alone, ICC = 0.047, and when the screening 
question was combined with a SPICT positive, ICC = 0.049.  If a future study had the 
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same median number of patients per GP as this study (n=124), then the design effect of 
the trial would be 6.8. 
 
Qualitative findings 
Eleven GP participants (5 female, 6 male) were interviewed. Participation in the study 
led them to consider end of life care management in their routine clinical practice 
positively. They felt that limited time and the opportunity cost of screening were 
important barriers to routine uptake of end of life screening. However they also 
identified that incorporating end of life screening tools into electronic medical records 
would assist in raising awareness of possible deterioration towards death, though the 
use of automated prompts on computer records when certain criteria were present, or 
prompting consideration of the SQ and SPICT in routine health assessments for older 
people. (Table 6) 
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Discussion 
Predicting death in general practice is difficult. Screening tools allowed better prediction 
of death than relying on intuition alone, but only within the people considered at risk. 
For the entire screened population, screening tools were no better than intuition in 
predicting death. However, attempting to identify people at risk of dying by any means 
raised the recognition of impending death approximately five- to seven-fold. All of the 
processes tested suffered from low sensitivity and high false positive rates.  
 
The high false positive rate is due to the low prevalence of dying in general practice. The 
higher the prevalence of a condition, the better the test characteristics. For example, 
Moroni and colleagues asked the GPs of patients with advanced cancer to apply the SQ 
to them, and demonstrated a positive predictive value of 83.8% at 12 months post 
assessment [13] compared with our result of 19%. 
 
The objective of identifying when someone enters the last year of life is to ensure that 
they and their family can be afforded the least distress and greatest comfort by 
providing the best possible care. Accurate prediction of a person’s death is not the main 
objective. Responses to patients identified by screening as nearing the end of life have 
to be timely and feasible for general practices, to be effective for patients and their 
carers.  
 
Active care planning in the final months of life improves quality of life[14] , reduces 
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hospitalization[15,16] and maintains function.[15]. However, in the Australian service 
environment where time is at a premium, the GP response to patients identified by 
routine screening would almost certainly be inadequate, as large numbers of false 
positive patients would all require a response. 
 
Therefore, accurate prediction of death is probably not the best signal of the need for 
end-of-life care planning in general practice. Recognising that the burden of illness is 
increasing may be a more appropriate goal. Intensive clinical care planning and service 
provision for all persons identified is not feasible, rather escalating levels of input by the 
primary care team as the person’s needs increase would be the ideal response. This 
approach could use a significant event like hospitalization or the onset of a new medical 
condition to trigger an assessment of the risk of dying.[17] Practice computers could be 
used to flag such events automatically, but the most important research task is to 
identify what these events are. [18] 
 
Strengths and weaknesses of the study 
We used an RCT to produce high-level evidence by ensuring balance in GP and patient 
characteristics prior to implementing the interventions. We believe the randomisation 
and approaches taken to minimise contamination taken were robust. However, this is a 
pilot study and the results have to be treated with caution. A major strength of the 
study was the use of state death registries to identify deaths.  
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There are weaknesses to the study. The use of intuition was a proxy for normal care, but 
asking the GPs to review lists and use intuition alone is in fact an intervention, and 
probably does not reflect normal practice. (Australian GPs are not encouraged to 
maintain palliative care registers) It can also be argued that using the SQ to identify 
patients at risk of dying is also purely intuitive, and so the trial was in effect testing only 
the ability of the SPICT. However, the proportion of people identified using the SQ was 
over twice that of asking GPs to use intuition alone, without the “surprise” descriptor. 
The SQ clearly guides intuition and does it very effectively.    This study required GPs to 
report on any patient they had seen on the list over 70 in the last two years. They may 
have misclassified patients for whom their knowledge was limited. Further, as the GPs 
manually checked the lists, patients may have been inadvertently overlooked. We 
experienced differential drop out rates, with more GPs in the SQ/SPICT group dropping 
out compared to the intuition group. This highlights the resource intensive nature of 
reviewing the list of patients systematically using prediction tools. 
 
Since all of the practices were group practices, more than one GP sometime assessed 
the same patient. As this was a pragmatic trial and not a population-based study of 
death rates, duplicate observations by multiple GPs of some patients was expected and 
not a study weakness.  The number of GPs not trained in Australia was significant, but 
numbers are small and it is unlikely to be of practical importance. The difference in 
proportion of female GPs in each group approached significance. Since these numbers 
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are of randomized GPs before dropouts, the difference was not likely to introduce 
systematic bias into the trial.   
Conclusion  
Screening for critical, low prevalence conditions normally requires a simple, easily 
administered test that has a low false positive rate. GP response to the test should 
prevent adverse consequences like preventable emergencies.  Accurate prognostication 
of dying several months from the event is very difficult in the general practice setting 
due to the low prevalence of the index event. It may be better to screen general 
practice patients for risk of accelerating deterioration towards death, rather than for the 
risk of death itself within a specified time frame. Reliable signals of this deterioration in 
general practice are yet to be determined. 
 
Health care systems that do not embed population-based surveillance in general 
practice, such as that in Australia, require novel approaches to identify and then deliver 
the best care for people who are approaching the end of their lives. Further research is 
needed to determine the best ways to identify the people in need of supportive care 
efficiently, so that the required planning and care is provided as effectively as possible. 
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Figure 1 – Participant (GP) Flow chart   
  
GPs Assessed for eligibility  
(n= 40) 
Excluded  (n=1) 
- Declined to participate (n=1) 
Analysed (GP n= 12; patients = 1525) 
- Excluded from analysis (n= 1; patients 
= 219; misidentified patient data) 
GPs lost to follow-up (n= 1; patients = 
416; no response to follow-up request) 
GPs allocated to predictive tools (n=19) 
- Received allocated intervention  
          (n= 13; patients = 1941) 
- Did not receive allocated intervention 
(n=6; 6 too busy) 
GPs lost to follow-up (n=0) 
GPs allocated to intuition (n=20) 
- Received allocated intervention (n= 
18; patients = 2840) 
- Did not receive allocated intervention 
(n=2; 2 too busy) 
Analysed (GP n= 18; patients = 2840) 
- Excluded from analysis (n=0) 
Allocation 
Analysis 
Follow-Up 
GPs Randomized 
Enrollment 
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Table 1    GP Characteristics (n=39) 
 
 Intuition  
(n=20) 
Screening Tools 
(n=19) 
  P 
Sex     
Female  6 (40%) 11 (58%)  0.08 
     
Age1    1.00 
 <=40 6 (35%) 7 (41%)   
41-50 3 (18%) 3 (18%)   
51-60 6 (35%) 6 (36%)   
61+ 2 (12%)         1 (  6%)   
     
Country of training    0.34 
Australia/ New 
Zealand 
15 (79%) 17 (94%)   
UK/ Ireland/Other 4 (21%) 1  (6%)   
     
Years in general practice   0.62 
<=10 7 (39%) 8 (44%)   
11 to 20 4 (22% 1 (  6%)   
21 to 30 4 (22%) 5 (28%)   
31 to 40+ 3 (17%) 4 (22%)   
      1. Missing items for intuition group: age, n=3; country of training, n=1; years in practice, n=2. Missing items for 
screening tools group: age, n=2; country of training, n=1; years in practice, n=1.  
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Table 2 Characteristics of patients and those predicted to die by general practitioners 
(GPs).  
(Intuition GPs were not given any prompts to identify patients at risk of dying, but were asked to provide 
reasons for their decision to identify individuals. Therefore, the entries in each column are not directly 
comparable and no statistical tests were conducted. Individuals could have more than one reason for 
being at risk of dying) 
 
 
 Tested by 
SQ/SPICT 
(n=1525) 
Tested by 
Intuition 
(n= 2840) 
   
Sex - Female  (n (%)) 512 (33.6) 1300 (29.8) 
Age - Years (Mean, (SD)) 79.1 (6.9) 
 
77.9 (6.3) 
 
Conditions 
(SPICT categories in italics  
Conditions identified by intuition only in normal 
type.)  
(n=179) (n=154) 
   
Cardiovascular   
Congestive Heart Failure 21 (11.7%) 35 (22.7%) 
Peripheral Vascular Disease 2 (1.1%) 19 (12.3%) 
Respiratory   
Respiratory impairment (Severe) 10 (5.6%) 12 (7.8%) 
Oxygen therapy 2 (1.1%)  
Respiratory impairment (moderate) - 23 (14.9%) 
Neurological   
Indicators of dementia/frailty:  - 
Deterioration 42 (23.5%)  
Dysphasia/Dysphagia 14 (7.8%) - 
Pneumonia/ respiratory infection   1 (0.6%) - 
Dementia - 34 (22.1%) 
Stroke (severe) - 3 (1.9%) 
  Other  - 37 (24%) 
Endocrine   
Diabetes - 30 (19.5%) 
Diabetes with end organ disease - 9 (5.8%) 
Other endocrine - 4 (2.6%) 
Renal   
CKD stage 4-5 
(+ with deteriorating health) 
- 
6 (3.4%) 
15 (9.7%) 
Failure from non-renal cause 1 (0.6%)  
Stopping dialysis 0 (0.0%)  
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CKD stage 1-3 - 16 (10.4%) 
Gastrointestinal   
Severe Liver disease 0 (0.0%) 4 (2.6%) 
Liver transplant indicated 0 (0.0%) - 
Active Peptic Ulcer - 2 (1.3%) 
   
Cancer   
Functional ability deteriorating from 
progressive metastatic cancer 
 
19 (6.3%) 
 
Too frail for oncology treatment or treatment 
for symptom control 
8 (2.3%)  
Cancer localised - 29 (18.8%) 
Cancer disseminated - 11 (7.1%) 
Lymphoma - 2 (1.3%) 
Other   
AIDS - 1 (0.6%) 
Rheumatologic conditions - 6 (3.9%) 
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Table 3- Number of Deaths and Proportions of Deaths at 12 Months 
Proportion of total 
population 
 
Intuition  
(n=2840) 
Screening tools  
(n=1525) 
MD1 (95%CI) P 
Total deaths  
  
95 (3.3%) 
 
47 (3.1%) 
 
-0.3%  
(-2.2%, 1.6%) 
0.79 
Predicted deaths 32 (1.1%) 25 (1.6%) 0.5%  
(-0.5%, 1.5%) 
0.33 
1MD- Mean Difference 2SQ+ - Surprise Question positive, SQ- - Surprise Question negative, 
SQU  - Surprise Question uncertain,  3SPICT+ positive identification by SPICT, SPICT-  negative 
identification by SPICT,    
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Table 4 – Test characteristics of screening methods compared to intuition. Differences between groups are presented as mean 
difference (MD) and 95% confidence interval (95%CI). There were 2840 patients in intuition group (95 deaths) and 1525 patients 
in screening (+/-SPICT) group (47 deaths) 
 
 Intuition 
(N=2840) 
(%) 
Screening 
(N=1525) 
(%) 
Screening vs 
intuition 
MD(95%CI) 
Screening 
vs 
intuition 
P-value 
Screening + 
SPICT 
(N=1525) 
(%) 
Screening+ 
SPICT vs 
intuition 
MD(95%CI) 
Screening
+SPICT vs 
intuition 
P-value 
Deaths, n(%) 95 (3.3%) 47 (3.1%) -0.3% 
(-2.2%, 1.6%) 
0.79 47 (3.1%) -0.3% 
(-2.2%, 1.6%) 
 
Predicted deaths, 
n(%) 
154 (5.4%) 179 (11.7%) 6.3% 
(1.4%, 11.2%) 
0.01 78 (5.1%) -0.3% 
(-4.0%, 3.4%) 
0.87 
Sensitivity, % 
(95%CI) 
33.7% 
(23.1%, 44.2%) 
53.2% 
(48.1%, 58.3%) 
19.5% 
(7.6%, 31.4%) 
0.001 34.0% 
(25.3%, 42.8%) 
0.4% 
(-13.7%, 14.4%) 
 
Specificity, % 
(95%CI) 
95.6% 
(93.8%, 97.3%) 
89.6% 
(85.5%, 93.7%) 
-6.0% 
(-10.4%, -
1.5%) 
0.009 95.8% 
(93.0%, 98.6%) 
0.2  
(-3.1%, 3.6%) 
 
PPV, % (95%CI) 20.8% 
(12.7%, 28.7%) 
14.0% 
(8.8%, 19.1%) 
-6.8% 
(-16.2,2.7%) 
0.16 20.5% 
(12.6, 28.4%) 
-0.3% 
(-11.5, 10.9%) 
0.96 
NPV, % (95%CI) 97.7% 
(96.8, 98.5%) 
98.4% 
(97.5%, 99.2%) 
0.7% 
(-0.5%,1.9%) 
0.24 97.9% 
(96.8%, 99.0 
0.2 
(-1.2%, 1.6%) 
0.78  
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Table 5 - Likelihood ratios and pre-post-test probability of Intuition, Surprise Question 
(SQ) screening only and SQ then SPICT 
 
 Intuition SQ1  
screening  
SQ then  
SPICT2 
 
Prevalence of death at 12 
months (Overall pre-test 
probability) 
3.3% 3.3% 
 
 
3.3% 
Test positive for possible death at 12 months 
Likelihood ratio  
(95%CI)  
7.6 
(5.4-10.6) 
5.1 
(3.8, 6.9) 
8.1 
(5.1-12.9) 
Post-test probability of dying 
(95%CI) 
20.5%   
(15.7%, 26.5%) 
14.8%  
(11.4%, 19.1%) 
 
20.5%  
(15.7%, 26.5%) 
Test negative for possible death at 12 months 
Likelihood ratio  
(95%CI) 
0.7  
(0.6-0.8) 
0.5  
(0.4, 0.7) 
0.7  
(0.6, 0.9) 
Post-test probability of dying 
(95%CI) 
2.3% (2.0%, 
2.7%) 
1.8% (1.3%, 
2.4%) 
2.3% (1.9, 2.8%)   
1 SQ- Surprise question   2SPICT- Supportive and Palliative care Indicator Tool 
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Table 6.  General practitioner views on the impact of, and facilitators and barriers to, 
systematic screening of people for risk of dying.  
Impact of study participation on perceptions of end of life care 
 "I guess it would prompt me to be more proactive about future planning… ‘cause at 
the moment, I probably would be waiting for quite – something quite disastrous to 
happen to the patient before I brought up anything about care or – they’d have to 
fall into a heap before that whole topic came up. So, yeah, so I think it would 
definitely change my management." (N07) 
 
Time and income foregone as barriers to implementation   
 
"It’s process that takes time and time is at a premium in general practice. It’s much 
easier just to do the episodic care and not to worry about any of the future planning 
and so on because it’s time consuming. So time would be a barrier." (Q03) 
 
"I’d find a way to fund it so that I could say to GPs we’re going to recognise your 
time, we’re going to pay the opportunity cost of you not seeing your patients for a 
couple of hours and then I’d find a way for those patients that are not being seen to 
be seen by somebody somehow some other time. " (Q01) 
 
 
Page 38 of 40
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Facilitators to implementation: Computer record system prompts 
"That would need to have some sort of automatic prompt…actually integrated into 
the medical [records] system... everyone above the age of 75 would come up as 
prompter, you want to do this, quality of life, end of life assessment, yes/no." (Q03) 
 
 Incorporation into routine aged care assessment 
“ I think it would help to systematize the way we manage older people, so it could be 
something that you slotted in, you may not do it with the patient but might sit it 
somewhere alongside the Over 75 Health Assessment1 because it’s got lots of 
questions… to include falls and fractures, hospitalizations, nutrition, how people are 
managing at home, et cetera. And so that would fit quite nicely alongside and we 
would be able to complete that in parallel.” (Q02) 
1.   The Over 75 Health assessment is a funded general review of patient wellbeing conducted for 
people over 75 years old, focusing on issues which may not come up in episodic consultations, like 
diet, social isolation or cognitive impairment.   
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CONSORT statement 
 
Item Page 
1a Title – includes “randomised controlled trial” 1 
1b  Abstract.  Reports Trial design, participant eligibility, participants, 
objective, outcomes, total number randomized but not by group, outcomes, 
conclusion.  There is a strict word limit of 250 words, so other issues were not 
in  the abstract: How randomisation occurred, recruitment/ trial status, 
numbers  analysed in each group, Harms (not relevant), trial registration and 
funding ( both reported elsewhere in the submission. 
6-7 
2a Background outlines rationale for study 10-12 
2b Objectives – present 12 
3a- trial design 13 
3b – there were no changes to the original trial design n/a 
4a- participant selection described 14 
4b- study setting described 13-14 
5.  Intervention described fully. 15-16 
6a Outcomes described fully and how they were assessed described, 13 
6b There were no changes to outcomes used. n/a 
7a  - No sample size was calculated. This was a pilot trial. We reported the 
calculated  Intracluster correlation and Design effect to assist investigators 
plan trials in the future is reported. 
22 
7b- Interim analysis and stopping guidelines – not relevant to this study n/a 
8a  Randomisation sequence generation described 14 
8b Type of randomisation described and blocking and stratification described  14 
9   Randomisation allocation concealment described (central randomisation 
and not advising the participants which arm they w re in) 
14,16 
10 Randomisation sequence  generation and assignment described. 14 
11a  Blinding technique described 16 
11b  Description of interventions  and data collection described, and 
interventions similar as much as possible 
15-16 
12a   Analytical methods fully described. 17 
12b   There were no subgroup analyses. n/a 
13a   Participant flow described and shown in Figure 1. Figure 1 
13b   Losses and exclusions shown and described as above 19, 
Figure 1 
14a   Recruitment dates shown 19 
14b   Reason trial stopped was as per funding timeline. Not mentioned n/a 
15     Baseline data for each group shown ( tables 1 for GPs and 2 for patients) 19 
Tables 
1,2 
16     Analysis by assigned group shown 20-21, 
Tables 
3-5 
17a   Outcomes with 95% confidence intervals shown – Tables 3-5 20-21, 
Tables 
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3-5 
17b    Binary outcomes ( died/ not died; predicted death/not predicted 
described, but absolute and relative risk ratios are not relevant. 
n/a 
18  No ancillary analyses performed. n/a 
19  Harms – not relevant to this study n/a 
20 Limitations discussed 25 
21 Generalisability- As this is a pilot RCT, generisability is not a factor. We have 
included a cautionary statement in the strengths and weaknesses section. 
24 
22.  Interpretation is consistent with results 23-24 
23  Trial registration number reported in abstract and text 7,18 
24  Trial protocol and data can be accessed  yes 
25   Trial funding sources presented. 5 
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